These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 1378833

  • 1. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.
    Nykjaer A, Petersen CM, Møller B, Jensen PH, Moestrup SK, Holtet TL, Etzerodt M, Thøgersen HC, Munch M, Andreasen PA.
    J Biol Chem; 1992 Jul 25; 267(21):14543-6. PubMed ID: 1378833
    [Abstract] [Full Text] [Related]

  • 2. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A, Kjøller L, Cohen RL, Lawrence DA, Garni-Wagner BA, Todd RF, van Zonneveld AJ, Gliemann J, Andreasen PA.
    J Biol Chem; 1994 Oct 14; 269(41):25668-76. PubMed ID: 7929271
    [Abstract] [Full Text] [Related]

  • 3. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
    Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, Blasi F.
    J Cell Biol; 1995 Dec 14; 131(6 Pt 1):1609-22. PubMed ID: 8522616
    [Abstract] [Full Text] [Related]

  • 4. Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor.
    Li H, Kuo A, Kochan J, Strickland D, Kariko K, Barnathan ES, Cines DB.
    J Biol Chem; 1994 Mar 18; 269(11):8153-8. PubMed ID: 7510679
    [Abstract] [Full Text] [Related]

  • 5. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase.
    Kounnas MZ, Henkin J, Argraves WS, Strickland DK.
    J Biol Chem; 1993 Oct 15; 268(29):21862-7. PubMed ID: 7691818
    [Abstract] [Full Text] [Related]

  • 6. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW, Kjoller L, Petersen HH, Andreasen PA.
    Biochem J; 1998 Jan 01; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
    Czekay RP, Kuemmel TA, Orlando RA, Farquhar MG.
    Mol Biol Cell; 2001 May 01; 12(5):1467-79. PubMed ID: 11359936
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of urokinase-type-1 inhibitor complex endocytosis by phorbol esters in different cell lines is associated with differential regulation of alpha 2-macroglobulin receptor and urokinase receptor expression.
    Kjøller L, Simonsen AC, Ellgaard L, Andreasen PA.
    Mol Cell Endocrinol; 1995 Apr 01; 109(2):209-17. PubMed ID: 7664984
    [Abstract] [Full Text] [Related]

  • 11. Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats.
    Moestrup SK, Holtet TL, Etzerodt M, Thøgersen HC, Nykjaer A, Andreasen PA, Rasmussen HH, Sottrup-Jensen L, Gliemann J.
    J Biol Chem; 1993 Jun 25; 268(18):13691-6. PubMed ID: 7685767
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library.
    Horn IR, Moestrup SK, van den Berg BM, Pannekoek H, Nielsen MS, van Zonneveld AJ.
    J Biol Chem; 1995 May 19; 270(20):11770-5. PubMed ID: 7538122
    [Abstract] [Full Text] [Related]

  • 13. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
    Ballance DJ, Marshall JM, Cottingham IR, Steven J, Berry SJ, Cederholm-Williams SA, Goodey AR, Courtney M.
    Eur J Biochem; 1992 Jul 01; 207(1):177-83. PubMed ID: 1321039
    [Abstract] [Full Text] [Related]

  • 14. Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor.
    Casslén B, Gustavsson B, Angelin B, Gåfvels M.
    Mol Hum Reprod; 1998 Jun 01; 4(6):585-93. PubMed ID: 9665342
    [Abstract] [Full Text] [Related]

  • 15. Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein.
    Willnow TE, Orth K, Herz J.
    J Biol Chem; 1994 Jun 03; 269(22):15827-32. PubMed ID: 7515061
    [Abstract] [Full Text] [Related]

  • 16. Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide.
    Zhang L, Strickland DK, Cines DB, Higazi AA.
    J Biol Chem; 1997 Oct 24; 272(43):27053-7. PubMed ID: 9341144
    [Abstract] [Full Text] [Related]

  • 17. Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes.
    Moestrup SK, Nielsen S, Andreasen P, Jørgensen KE, Nykjaer A, Røigaard H, Gliemann J, Christensen EI.
    J Biol Chem; 1993 Aug 05; 268(22):16564-70. PubMed ID: 8344937
    [Abstract] [Full Text] [Related]

  • 18. Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.
    Andersen OM, Petersen HH, Jacobsen C, Moestrup SK, Etzerodt M, Andreasen PA, Thøgersen HC.
    Biochem J; 2001 Jul 01; 357(Pt 1):289-96. PubMed ID: 11415462
    [Abstract] [Full Text] [Related]

  • 19. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.
    Ragno P, Montuori N, Rossi G.
    Eur J Biochem; 1995 Oct 15; 233(2):514-9. PubMed ID: 7588796
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A.
    J Hepatol; 1999 Oct 15; 31(4):703-11. PubMed ID: 10551395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.